Trondheim, Norway

Pal Saetrom

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pal Saetrom

Introduction

Pal Saetrom is a notable inventor based in Trondheim, Norway. He has made significant contributions to the field of molecular biology, particularly in the development of short interfering RNA (siRNA) technologies. With a total of 6 patents to his name, Saetrom's work has the potential to impact various therapeutic applications.

Latest Patents

One of Saetrom's latest patents focuses on multi-targeting short interfering RNAs. This invention relates to novel siRNA molecules that are designed to target two or more sequences simultaneously. In one embodiment, these multi-targeting siRNA molecules incorporate features of both siRNA and micro-RNA (miRNA) molecules. In another embodiment, each strand of the multi-targeting siRNA is directed to separate targets, enhancing the versatility and effectiveness of RNA-based therapies.

Career Highlights

Throughout his career, Pal Saetrom has worked with esteemed organizations such as City of Hope and Mina Therapeutics Limited. His innovative research has positioned him as a key figure in the advancement of RNA technology, contributing to the understanding and application of gene silencing mechanisms.

Collaborations

Saetrom has collaborated with notable colleagues in the field, including John J Rossi and Ola Snove. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of scientific knowledge.

Conclusion

Pal Saetrom's contributions to the field of molecular biology, particularly through his innovative patents on multi-targeting siRNA, highlight his role as a leading inventor. His work continues to pave the way for advancements in RNA-based therapies and gene silencing technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…